Diversifying in biotech
Article Abstract:
Investors seeking diversification often turn to mutual funds (unit trusts in the UK and elsewhere) and biotech investors can use various tools to spread their risks as well. Though there are two commonly used indexes of US biotech stock market performance such as the American Stock Exchange Biotechnology Index and the Nasdaq Biotechnology Index, biotech investors have one major index investing option.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Does biotech M&A benefit investors?
Article Abstract:
The effect of merging as a benefit to investors is detailed. It is observed that the best performing companies do not merge and if a company of any size is in trouble, it certainly is better for employees and their communities if they merge than not, for investors the expectations for such mergers are so high that the results are usually mediocre or worse.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Biotech IPOs: handle with care
Article Abstract:
Tom Jacob's views on biotechnology investments are discussed. The initial public offerings (IPOs) are financing events for companies and so no great opportunities are left for investors.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The number on biotech indexes. Putting biotech risk in its place. Going short on biotech
- Abstracts: Canada's bumper biotech budget. Angel investors shy away from biotech
- Abstracts: Conclusions: Promoting biotechnology innovation in developing countries. Biotechnology and the UN's millennium development goals